By utilizing the specific homing properties of exosomes, HELA-Exos were successfully accumulated in the TME, inducing tumor ICD to release tumor antigens, and observed that in situ cDC1s were activated and initiated tumor-reactive CD8+T cell responses, showing strong anti-tumor activity in mouse models and human breast cancer organoids. Here, CD8A is linked to neoplasm.